Innocan Pharma (INNO.CN) Stock Price
Innocan Pharma Price
Over the last 4 years Innocan Pharma grew revenue by 678.8% annually, reaching 29.44 M USD. For Innocan Pharma, the net margin of -6.2% is up versus -124,412.5% a few years ago.
Innocan Pharma stock price
Innocan Pharma business model & stock analysis
Frequently asked questions about Innocan Pharma
Converted at the current exchange rate, the Innocan Pharma share trades at 1.13 EUR (1.26 USD).
The Innocan Pharma share (INNO.CN) is listed on 6 stock exchanges, including: Frankfurt (IP4.F), München (IP4.MU), Düsseldorf (IP4.DU), Hamburg (IP4.HM).
The revenue cannot currently be calculated for Innocan Pharma.
The profit cannot currently be calculated for Innocan Pharma.
The P/E ratio cannot be calculated for Innocan Pharma at the moment.
The P/S cannot be calculated for Innocan Pharma currently.
The Eulerpool Quality Score for Innocan Pharma is 2/10.
The ISIN of Innocan Pharma is CA45783P5085. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Innocan Pharma is A2PSPW. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Innocan Pharma is INNO.CN. The ticker symbol is used to trade Innocan Pharma shares on the stock exchange.
Innocan Pharma stock
Innocan Pharma Peer Group
Innocan Pharma Ticker
All fundamentals and in-depth analysis of Innocan Pharma
Our stock analysis for Innocan Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Innocan Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.